4 stories mentioning SHE:002737Updated 19d ago
Every FINWIRES story that references SHE:002737, newest first.
Sunflower Pharmaceutical (SHE:002737) withdrew its 1-million-yuan investment in the Hangzhou Xiaochi Fund and will transfer its partnership share to an individual investor, according to a Tuesday filing with the Shenzhen bourse.The sale to individual investor Wu Mingxing will help the company focus on its core operations, improve its investment structure, and boost capital operations efficiency.
Sunflower Pharmaceutical (SHE:002737) agreed to invest 10 million yuan to establish a subsidiary, according to a Shenzhen bourse filing on Tuesday.The subsidiary, to be named Sichuan Kuihua Pharmaceutical, will be a wholesaler and retailer of pharmaceutical products and will be located in Chengdu, Sichuan Province, China.
Sunflower Pharmaceutical (SHE:002737) agreed to dispose of its 10.4% equity in Beijing Pharmastar Pharmaceutical Technology for a consideration of 34.3 million yuan, according to a Shenzhen bourse filing on Tuesday.Guangzhou Baiyunshan Hejigong Pharmaceutical will acquire the stake.After the transaction, the Chinese medicine group will no longer hold any stake in Pharmastar.
Three of Sunflower Pharmaceutical's (SHE:002737) products were provisionally selected for China's centralized volume-based procurement program for traditional medicines.The Chinese medicine group's liver protection tablets, children's lung heat cough oral liquid/granules and digestive tablets were picked during the fourth batch of the National Traditional Chinese Medicine Procurement Alliance project, according to a Wednesday filing with the Shenzhen bourse.Shares of the company closed 2% lower Wednesday.
